Bergholm A M, Dornbusch K
Dept. of Clinical Bacteriology, University of Umeå, Sweden.
APMIS. 1990 Mar;98(3):269-75. doi: 10.1111/j.1699-0463.1990.tb01031.x.
Isolates of Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae and Klebsiella pneumoniae were tested for their bactericidal activity and postantibiotic effect (PAE) with the new penem FCE 22101. The tissue cage model in rabbits was used to study PAE in vivo. The bactericidal activity against all four species was shown to be in the range of 0.05-4.0 mg/l. A 99.9% killing effect at MBC concentrations was reached within 2 hours with S. pneumoniae and K. pneumoniae and within 6-8 hours with S. aureus and H. influenzae. After in vitro exposure by FCE 22101 a PAE in vitro and in vivo was obtained against S. aureus, S. pneumoniae and H. influenzae strains but no PAE could be demonstrated against K. pneumoniae. FCE 22101 showed a good bactericidal activity and PAE against the strains investigated, except for K. pneumoniae.
对金黄色葡萄球菌、肺炎链球菌、流感嗜血杆菌和肺炎克雷伯菌的分离株,用新型青霉烯类抗生素FCE 22101检测其杀菌活性和抗生素后效应(PAE)。采用家兔组织笼模型研究体内PAE。对所有这四种菌的杀菌活性显示在0.05 - 4.0毫克/升范围内。肺炎链球菌和肺炎克雷伯菌在MBC浓度下2小时内达到99.9%的杀菌效果,金黄色葡萄球菌和流感嗜血杆菌在6 - 8小时内达到该效果。经FCE 22101体外作用后,对金黄色葡萄球菌、肺炎链球菌和流感嗜血杆菌菌株获得了体外和体内PAE,但对肺炎克雷伯菌未显示出PAE。除肺炎克雷伯菌外,FCE 22101对所研究的菌株显示出良好的杀菌活性和PAE。